Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200511047396N1
IRCT20200511047396N1
Recruiting
Phase 3

Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients

CinnaGen company0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID-19.COVID-19, virus identifiedU07.1

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
COVID-19.
Sponsor
CinnaGen company
Enrollment
50
Status
Recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients who have Covid\-19 based on the CT\-scan or RT\-PCR findings
  • •Hospitalized patients
  • •Willingness to participate in the study for trial period and signing the informed consent form
  • •Age between 20\-65

Exclusion Criteria

  • •Breastfeeding
  • •Use of ARB/ACEi
  • •History of hypotension
  • •have no consent to participate in the study
  • •Allergic sensitivity to the interferon products
  • •Not availability of phone number or it is possible to be transferred to other hospitals
  • •Having the CKD or patients who need dialysis at the begining of the study
  • •Having any disease or condition that based on the physician judgment cannot participate in the study
  • •Participation in any other trials of Covid\-19

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of the technique of using inhalation devices in asthmatic patients after training
RBR-2kwny8Faculdade de Medicina da Universidade Federal Fluminense
Not yet recruiting
Phase 4
Efficacy Of Intranasal Tapentadol In Pain Management In Opioid Use DisorderHealth Condition 1: F112- Opioid dependence
CTRI/2021/09/036462GMC RH Patiala
Recruiting
Not Applicable
Investigation of effectiveness of inhalation intake of beta-caryophyllene (BCP) against vascular wall stiffening caused by smoking.Smoker
JPRN-UMIN000049675Sunsho Pharmaceutical Co.,Ltd.90
Active, not recruiting
Not Applicable
Improving health outcomes for Jordanian outpatients with asthmaAsthmaRespiratory - Asthma
ACTRN12610000159055Applied Science University114
Not yet recruiting
Phase 4
Evaluation of nasal administration of extract of Brahmi leaves (INDCA-NS) in the treatment of tension-type headache
CTRI/2020/10/028285Indus Biotech Private Limited